|
|
|
Volumn 52, Issue 10, 2003, Pages 748-751
|
|
Tapering inhaled steroids effective for chronic asthma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BECLOMETASONE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BUDESONIDE;
CORTICOSTEROID;
FLUTICASONE;
LONG ACTING DRUG;
STEROID;
ADULT;
ASTHMA;
CHRONIC DISEASE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONSULTATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE CONTROL;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG DOSE REDUCTION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
FOLLOW UP;
GENERAL PRACTITIONER;
HEALTH STATUS;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
OUTCOMES RESEARCH;
PRACTICE GUIDELINE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
STEROID THERAPY;
SYMPTOM;
TECHNIQUE;
UNITED KINGDOM;
ADMINISTRATION, INHALATION;
ADULT;
ANDROSTADIENES;
ANTI-ASTHMATIC AGENTS;
ANTI-INFLAMMATORY AGENTS;
ASTHMA;
BECLOMETHASONE;
CHRONIC DISEASE;
DOUBLE-BLIND METHOD;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0141954061
PISSN: 00943509
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (0)
|
